Scholar Data
Sign in

Automated Author Profile

Fink, Marc

Current S-Index

8.3

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

1.0

Average Dataset Index per dataset

Total Datasets

8

Total datasets for this author

Average FAIR Score

39.7%

Average FAIR Score per dataset

Total Citations

8

Total citations to the author's datasets

Total Mentions

0

Total mentions of the author's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

Additional file 12: Figure S9A and B. of Development and clinical application of an integrative genomic approach to personalized cancer therapy

CLPB-NADSYN1 gene fusion in patient P0002. a Long-range PCR confirms CLPB-NADSYN1 gene fusion. b Genomic breakpoint of CLPB-NADSYN1 gene fusion. (ZIP 150 kb)

Authors

  • Uzilov, Andrew ;
  • Ding, Wei ;
  • Fink, Marc ;
  • Antipin, Yevgeniy ;
  • Brohl, Andrew ;
  • Davis, Claire ;
  • Lau, Chun ;
  • Chetanya Pandya ;
  • Hardik Shah ;
  • Kasai, Yumi ;
  • Powell, James ;
  • Micchelli, Mark ;
  • Castellanos, Rafael ;
  • Zhongyang Zhang ;
  • Linderman, Michael ;
  • Kinoshita, Yayoi ;
  • Zweig, Micol ;
  • Raustad, Katie ;
  • Kakit Cheung ;
  • Castillo, Diane ;
  • Wooten, Melissa ;
  • Bourzgui, Imane ;
  • Newman, Leah ;
  • Deikus, Gintaras ;
  • Bino Mathew ;
  • Zhu, Jun ;
  • Glicksberg, Benjamin ;
  • Aye Moe ;
  • Liao, Jun ;
  • Edelmann, Lisa ;
  • Dudley, Joel ;
  • Maki, Robert ;
  • Kasarskis, Andrew ;
  • Holcombe, Randall ;
  • Milind Mahajan ;
  • Hao, Ke ;
  • Reva, Boris ;
  • Longtine, Janina ;
  • Starcevic, Daniela ;
  • Sebra, Robert ;
  • Donovan, Michael ;
  • Shuyu Li ;
  • Schadt, Eric ;
  • Chen, Rong
1 Citation0 Mentions81% FAIR2.1 Dataset Index
10.6084/m9.figshare.c.3605855_d6January 2016

Additional file 1: of Development and clinical application of an integrative genomic approach to personalized cancer therapy

Supplementary Tables: Tables S1-S11. See Additional file 2 for detailed table legends. (XLSX 144 kb)

Authors

  • Uzilov, Andrew ;
  • Ding, Wei ;
  • Fink, Marc ;
  • Antipin, Yevgeniy ;
  • Brohl, Andrew ;
  • Davis, Claire ;
  • Lau, Chun ;
  • Chetanya Pandya ;
  • Hardik Shah ;
  • Kasai, Yumi ;
  • Powell, James ;
  • Micchelli, Mark ;
  • Castellanos, Rafael ;
  • Zhongyang Zhang ;
  • Linderman, Michael ;
  • Kinoshita, Yayoi ;
  • Zweig, Micol ;
  • Raustad, Katie ;
  • Kakit Cheung ;
  • Castillo, Diane ;
  • Wooten, Melissa ;
  • Bourzgui, Imane ;
  • Newman, Leah ;
  • Deikus, Gintaras ;
  • Bino Mathew ;
  • Zhu, Jun ;
  • Glicksberg, Benjamin ;
  • Aye Moe ;
  • Liao, Jun ;
  • Edelmann, Lisa ;
  • Dudley, Joel ;
  • Maki, Robert ;
  • Kasarskis, Andrew ;
  • Holcombe, Randall ;
  • Milind Mahajan ;
  • Hao, Ke ;
  • Reva, Boris ;
  • Longtine, Janina ;
  • Starcevic, Daniela ;
  • Sebra, Robert ;
  • Donovan, Michael ;
  • Shuyu Li ;
  • Schadt, Eric ;
  • Chen, Rong
1 Citation0 Mentions13% FAIR0.5 Dataset Index
10.6084/m9.figshare.c.3605855_d8January 2016

Additional file 6: Figure S3A and B. of Development and clinical application of an integrative genomic approach to personalized cancer therapy

Comparison of somatic CNA segment properties (number and length) between joint segmentation calls by saasCNV ( https://zhangz05.u.hpc.mssm.edu/saasCNV ) from WES data versus array data. Only samples where both assays were run on same DNA extraction are shown. All segments are shown, including those classified as “normal” (no CNA) and “undecided” (unclear CNA change). Patient P0040 is shown twice, once for each of the two tumors assayed, though in both cases the same normal control data is used. “FFPE” and “frozen” in all plots refers to tissue source of tumor DNA. a Correlation of total segment number per tumor between WES and array assays. b Violin plot comparing the distribution of segment lengths between WES and array assays for each tumor. Boxplot within each violin plot shows median, 25th, and 75th quantiles. (ZIP 229 kb)

Authors

  • Uzilov, Andrew ;
  • Ding, Wei ;
  • Fink, Marc ;
  • Antipin, Yevgeniy ;
  • Brohl, Andrew ;
  • Davis, Claire ;
  • Lau, Chun ;
  • Chetanya Pandya ;
  • Hardik Shah ;
  • Kasai, Yumi ;
  • Powell, James ;
  • Micchelli, Mark ;
  • Castellanos, Rafael ;
  • Zhongyang Zhang ;
  • Linderman, Michael ;
  • Kinoshita, Yayoi ;
  • Zweig, Micol ;
  • Raustad, Katie ;
  • Kakit Cheung ;
  • Castillo, Diane ;
  • Wooten, Melissa ;
  • Bourzgui, Imane ;
  • Newman, Leah ;
  • Deikus, Gintaras ;
  • Bino Mathew ;
  • Zhu, Jun ;
  • Glicksberg, Benjamin ;
  • Aye Moe ;
  • Liao, Jun ;
  • Edelmann, Lisa ;
  • Dudley, Joel ;
  • Maki, Robert ;
  • Kasarskis, Andrew ;
  • Holcombe, Randall ;
  • Milind Mahajan ;
  • Hao, Ke ;
  • Reva, Boris ;
  • Longtine, Janina ;
  • Starcevic, Daniela ;
  • Sebra, Robert ;
  • Donovan, Michael ;
  • Shuyu Li ;
  • Schadt, Eric ;
  • Chen, Rong
1 Citation0 Mentions13% FAIR0.6 Dataset Index
10.6084/m9.figshare.c.3605855_d9January 2016

Additional file 13: of Development and clinical application of an integrative genomic approach to personalized cancer therapy

A gzipped tarball (.tgz file) of VCF files containing somatic mutations (i.e. present exclusively in tumor) for the 25 patients (one VCF file per patient) on whom paired normal/tumor WES was carried out and whose consents permitted public release of the full variant call data. For patients where multiple assays were carried out (WGS, WES, targeted panel, PacBio validation for troubleshooting), the VCF file contains the final variant call set where any discordance amongst the assays was resolved. Only mutations altering amino acid sequence (missense, nonsense, canonical splice site, indel) in a canonical isoform of a gene are given. Mutations are included that are not explicitly reported in returned findings due to lack of known relevance to cancer. Mutations rejected during our manual review protocol are not included. Thus, VCFs may contain mutations that were not manually reviewed. Three patients (P0009, P0025, and P0040) have two tumor specimens available, therefore those VCFs are multi-sample and report which mutations are recurrent among tumors and which are not; the rest are single-sample. (ZIP 37 kb)

Authors

  • Uzilov, Andrew ;
  • Ding, Wei ;
  • Fink, Marc ;
  • Antipin, Yevgeniy ;
  • Brohl, Andrew ;
  • Davis, Claire ;
  • Lau, Chun ;
  • Chetanya Pandya ;
  • Hardik Shah ;
  • Kasai, Yumi ;
  • Powell, James ;
  • Micchelli, Mark ;
  • Castellanos, Rafael ;
  • Zhongyang Zhang ;
  • Linderman, Michael ;
  • Kinoshita, Yayoi ;
  • Zweig, Micol ;
  • Raustad, Katie ;
  • Kakit Cheung ;
  • Castillo, Diane ;
  • Wooten, Melissa ;
  • Bourzgui, Imane ;
  • Newman, Leah ;
  • Deikus, Gintaras ;
  • Bino Mathew ;
  • Zhu, Jun ;
  • Glicksberg, Benjamin ;
  • Aye Moe ;
  • Liao, Jun ;
  • Edelmann, Lisa ;
  • Dudley, Joel ;
  • Maki, Robert ;
  • Kasarskis, Andrew ;
  • Holcombe, Randall ;
  • Milind Mahajan ;
  • Hao, Ke ;
  • Reva, Boris ;
  • Longtine, Janina ;
  • Starcevic, Daniela ;
  • Sebra, Robert ;
  • Donovan, Michael ;
  • Shuyu Li ;
  • Schadt, Eric ;
  • Chen, Rong
1 Citation0 Mentions13% FAIR0.5 Dataset Index
10.6084/m9.figshare.c.3605855_d12January 2016

Additional file 13: of Development and clinical application of an integrative genomic approach to personalized cancer therapy

A gzipped tarball (.tgz file) of VCF files containing somatic mutations (i.e. present exclusively in tumor) for the 25 patients (one VCF file per patient) on whom paired normal/tumor WES was carried out and whose consents permitted public release of the full variant call data. For patients where multiple assays were carried out (WGS, WES, targeted panel, PacBio validation for troubleshooting), the VCF file contains the final variant call set where any discordance amongst the assays was resolved. Only mutations altering amino acid sequence (missense, nonsense, canonical splice site, indel) in a canonical isoform of a gene are given. Mutations are included that are not explicitly reported in returned findings due to lack of known relevance to cancer. Mutations rejected during our manual review protocol are not included. Thus, VCFs may contain mutations that were not manually reviewed. Three patients (P0009, P0025, and P0040) have two tumor specimens available, therefore those VCFs are multi-sample and report which mutations are recurrent among tumors and which are not; the rest are single-sample. (ZIP 37 kb)

Authors

  • Uzilov, Andrew ;
  • Ding, Wei ;
  • Fink, Marc ;
  • Antipin, Yevgeniy ;
  • Brohl, Andrew ;
  • Davis, Claire ;
  • Lau, Chun ;
  • Chetanya Pandya ;
  • Hardik Shah ;
  • Kasai, Yumi ;
  • Powell, James ;
  • Micchelli, Mark ;
  • Castellanos, Rafael ;
  • Zhongyang Zhang ;
  • Linderman, Michael ;
  • Kinoshita, Yayoi ;
  • Zweig, Micol ;
  • Raustad, Katie ;
  • Kakit Cheung ;
  • Castillo, Diane ;
  • Wooten, Melissa ;
  • Bourzgui, Imane ;
  • Newman, Leah ;
  • Deikus, Gintaras ;
  • Bino Mathew ;
  • Zhu, Jun ;
  • Glicksberg, Benjamin ;
  • Aye Moe ;
  • Liao, Jun ;
  • Edelmann, Lisa ;
  • Dudley, Joel ;
  • Maki, Robert ;
  • Kasarskis, Andrew ;
  • Holcombe, Randall ;
  • Milind Mahajan ;
  • Hao, Ke ;
  • Reva, Boris ;
  • Longtine, Janina ;
  • Starcevic, Daniela ;
  • Sebra, Robert ;
  • Donovan, Michael ;
  • Shuyu Li ;
  • Schadt, Eric ;
  • Chen, Rong
1 Citation0 Mentions13% FAIR0.6 Dataset Index
10.6084/m9.figshare.c.3605855_d12.v1January 2016

Additional file 6: Figure S3A and B. of Development and clinical application of an integrative genomic approach to personalized cancer therapy

Comparison of somatic CNA segment properties (number and length) between joint segmentation calls by saasCNV ( https://zhangz05.u.hpc.mssm.edu/saasCNV ) from WES data versus array data. Only samples where both assays were run on same DNA extraction are shown. All segments are shown, including those classified as “normal” (no CNA) and “undecided” (unclear CNA change). Patient P0040 is shown twice, once for each of the two tumors assayed, though in both cases the same normal control data is used. “FFPE” and “frozen” in all plots refers to tissue source of tumor DNA. a Correlation of total segment number per tumor between WES and array assays. b Violin plot comparing the distribution of segment lengths between WES and array assays for each tumor. Boxplot within each violin plot shows median, 25th, and 75th quantiles. (ZIP 229 kb)

Authors

  • Uzilov, Andrew ;
  • Ding, Wei ;
  • Fink, Marc ;
  • Antipin, Yevgeniy ;
  • Brohl, Andrew ;
  • Davis, Claire ;
  • Lau, Chun ;
  • Chetanya Pandya ;
  • Hardik Shah ;
  • Kasai, Yumi ;
  • Powell, James ;
  • Micchelli, Mark ;
  • Castellanos, Rafael ;
  • Zhongyang Zhang ;
  • Linderman, Michael ;
  • Kinoshita, Yayoi ;
  • Zweig, Micol ;
  • Raustad, Katie ;
  • Kakit Cheung ;
  • Castillo, Diane ;
  • Wooten, Melissa ;
  • Bourzgui, Imane ;
  • Newman, Leah ;
  • Deikus, Gintaras ;
  • Bino Mathew ;
  • Zhu, Jun ;
  • Glicksberg, Benjamin ;
  • Aye Moe ;
  • Liao, Jun ;
  • Edelmann, Lisa ;
  • Dudley, Joel ;
  • Maki, Robert ;
  • Kasarskis, Andrew ;
  • Holcombe, Randall ;
  • Milind Mahajan ;
  • Hao, Ke ;
  • Reva, Boris ;
  • Longtine, Janina ;
  • Starcevic, Daniela ;
  • Sebra, Robert ;
  • Donovan, Michael ;
  • Shuyu Li ;
  • Schadt, Eric ;
  • Chen, Rong
1 Citation0 Mentions13% FAIR0.6 Dataset Index
10.6084/m9.figshare.c.3605855_d9.v1January 2016

Additional file 1: of Development and clinical application of an integrative genomic approach to personalized cancer therapy

Supplementary Tables: Tables S1-S11. See Additional file 2 for detailed table legends. (XLSX 144 kb)

Authors

  • Uzilov, Andrew ;
  • Ding, Wei ;
  • Fink, Marc ;
  • Antipin, Yevgeniy ;
  • Brohl, Andrew ;
  • Davis, Claire ;
  • Lau, Chun ;
  • Chetanya Pandya ;
  • Hardik Shah ;
  • Kasai, Yumi ;
  • Powell, James ;
  • Micchelli, Mark ;
  • Castellanos, Rafael ;
  • Zhongyang Zhang ;
  • Linderman, Michael ;
  • Kinoshita, Yayoi ;
  • Zweig, Micol ;
  • Raustad, Katie ;
  • Kakit Cheung ;
  • Castillo, Diane ;
  • Wooten, Melissa ;
  • Bourzgui, Imane ;
  • Newman, Leah ;
  • Deikus, Gintaras ;
  • Bino Mathew ;
  • Zhu, Jun ;
  • Glicksberg, Benjamin ;
  • Aye Moe ;
  • Liao, Jun ;
  • Edelmann, Lisa ;
  • Dudley, Joel ;
  • Maki, Robert ;
  • Kasarskis, Andrew ;
  • Holcombe, Randall ;
  • Milind Mahajan ;
  • Hao, Ke ;
  • Reva, Boris ;
  • Longtine, Janina ;
  • Starcevic, Daniela ;
  • Sebra, Robert ;
  • Donovan, Michael ;
  • Shuyu Li ;
  • Schadt, Eric ;
  • Chen, Rong
1 Citation0 Mentions85% FAIR1.3 Dataset Index
10.6084/m9.figshare.c.3605855_d8.v1January 2016

Additional file 12: Figure S9A and B. of Development and clinical application of an integrative genomic approach to personalized cancer therapy

CLPB-NADSYN1 gene fusion in patient P0002. a Long-range PCR confirms CLPB-NADSYN1 gene fusion. b Genomic breakpoint of CLPB-NADSYN1 gene fusion. (ZIP 150 kb)

Authors

  • Uzilov, Andrew ;
  • Ding, Wei ;
  • Fink, Marc ;
  • Antipin, Yevgeniy ;
  • Brohl, Andrew ;
  • Davis, Claire ;
  • Lau, Chun ;
  • Chetanya Pandya ;
  • Hardik Shah ;
  • Kasai, Yumi ;
  • Powell, James ;
  • Micchelli, Mark ;
  • Castellanos, Rafael ;
  • Zhongyang Zhang ;
  • Linderman, Michael ;
  • Kinoshita, Yayoi ;
  • Zweig, Micol ;
  • Raustad, Katie ;
  • Kakit Cheung ;
  • Castillo, Diane ;
  • Wooten, Melissa ;
  • Bourzgui, Imane ;
  • Newman, Leah ;
  • Deikus, Gintaras ;
  • Bino Mathew ;
  • Zhu, Jun ;
  • Glicksberg, Benjamin ;
  • Aye Moe ;
  • Liao, Jun ;
  • Edelmann, Lisa ;
  • Dudley, Joel ;
  • Maki, Robert ;
  • Kasarskis, Andrew ;
  • Holcombe, Randall ;
  • Milind Mahajan ;
  • Hao, Ke ;
  • Reva, Boris ;
  • Longtine, Janina ;
  • Starcevic, Daniela ;
  • Sebra, Robert ;
  • Donovan, Michael ;
  • Shuyu Li ;
  • Schadt, Eric ;
  • Chen, Rong
1 Citation0 Mentions85% FAIR2.2 Dataset Index
10.6084/m9.figshare.c.3605855_d6.v1January 2016